RESEARCH PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Arterial blood pressure is one of the main vital signs reflecting body functions and, at the same time, the most important functional parameter of the cardiovascular system. High blood pressure is the major modifiable cardiovascular risk factor.

Objective:
The aim of the study was assessment of the frequency of occurrence of cardiovascular risk factors, with particular consideration of arterial blood pressure.

Material and methods:
The study was conducted among 509 volunteers from Lublin in eastern Poland who participated in the prophylactic programme entitled ‘White Sunday’. Standard measurements of blood pressure were performed using a TM-Z dial pressure gauge. The level of arterial blood pressure and socio-demographic parameters were analyzed.

Results:
Hypertension was more frequently observed in the group of males than females. The age group especially vulnerable to abnormal blood pressure values were those aged 51–60. Isolated hypertension significantly more often occurred in the group of respondents who mentioned hypertension in an interview, compared to those who reported its absence. Among 367 persons who, in preliminary interview, did not declare hypertension, 60 cases of isolated arterial hypertension were noted (16.3%). From among respondents who declared absence of hypertension in an interview, the largest age group diagnosed with isolated arterial hypertension were those aged 61–70 (17.9%).

Conclusions:
Arterial hypertension is a civilisation disease which may be effectively prevented, simultaneously reducing the risk of premature death due to cardiovascular events, as well as reducing social and economic costs. International health organizations recommend the implementation of social screening programmes in order to diagnose high blood pressure and the promotion of routine measurements of arterial blood pressure.

 
REFERENCES (45)
1.
Konturek S. Fizjologia człowieka. Układ krążenia. Wydawnictwo Uniwersytetu Jagiellońskiego. Kraków, 2016; 2.
 
2.
Nicolas Postel-Vinay A. Century of Arterial Hypertension 1896-1996. Wiley. Chichester, 1996.
 
3.
Januszewicz W, Dworzański W, Prejbisz A, Januszewicz A. Nadciśnienie tętnicze wtórne - co nowego? Choroby Serca i Naczyń. 2015;12(1):15-18.
 
4.
Szymański FM. Standardowe i uzupełniające metody pomiaru wartości ciśnienia tętniczeg - o czym należy pamiętać? Choroby Serca i Naczyń 2013; 10(5):243–249.
 
5.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014; 383(9921): 999-1008. https://doi.org/10.1016/s0140-....
 
6.
Stanaway JD, Afshin A, Gakidou E, Lim SS, Abate D, Abate KH, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1923–94. https://doi.org/10.1016/s0140-....
 
7.
Brauer M, Casadei B, Harrington RA, Kovacs R, Sliwa K. Expert Group the WAP. Taking a Stand Against Air Pollution – The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. Global Heart. 2021;16(1):8. http://doi.org/10.5334/gh.948.
 
8.
Newby DE, Mannucci PM, Tell GS, et al. Expert position paper on air pollution and cardiovascular disease. Eur Heart J. 2015; 36(2): 83–93. https://doi.org/10.1093/eurhea....
 
9.
Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. https://doi.org/10.1016/s0140-....
 
10.
World Health Organization. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. World Health Organization. https://apps.who.int/iris/hand... License: CC BY-NC-SA 3.0 IGO. (access: 2020.10.09).
 
11.
World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. Resolution WHA66.10. https://www.who.int/publicatio... (access: 2020.10.09).
 
12.
Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and Control of Hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018; 72 (11): 1278–1293.
 
13.
ONZ. Rezolucja Zgromadzenia Ogólnego A/RES/70/1: Agenda na Rzecz Zrównoważonego Rozwoju 2030. A/RES/70/1.
 
14.
Adler AJ, Prabhakaran D, Bovet P, Kazi DS, Mancia G , et al. Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure A World Heart Federation Roadmap. Global Heart, 2015; 10 (2): 111-122.
 
15.
Pioli MR, Ritter AM, de Faria AP, Modolo R. White coat syndrome and its variations: differences and clinical impact. Integr Blood Press Control. 2018;11:73-79. https://dx.doi.org/10.2147%2FI....
 
16.
Polish Society of Hypertension. Principles of management of arterial hypertension — 2019. Guidelines by the Polish Society of Hypertension. Arterial Hypertension in Practice. 2019;5(1):1–86.
 
17.
Whelton PK, Carey RM. The 2017 clinical practice guideline for high blood pressure. JAMA. 2017; 318(21): 2073–2074. https://doi.org/10.1001/jama.2....
 
18.
World Health Organization. Global NCD target: reduce high blood pressure. WHO. 2016. https://www.who.int/publicatio... (access: 2020.10.09).
 
19.
Koracevic G. Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin. Med Princ Pract. 2020;29:301–309. DOI: 10.1159/000508462.
 
20.
Kim S, Lee J, Kim W, Kim YH, et al. Central hemodynamic characteristics of young adults with isolated systolic hypertension: an ambulatory blood pressure monitoring-based study of real-world clinical patients. Hypertens Res. 2019; 43: 197–206 (2020). https://doi.org/10.1038/s41440....
 
21.
Jan S, Laba TL, Essue BM, Gheorghe A, Muhunthan J, et al. Action to address the household economic burden of non-communicable diseases. Lancet. 2018;391(10134): 2047-2058. https://doi.org/10.1016/s0140-....
 
22.
Choromańska A, Szumiał Sz, Czerw A. Indirect costs of arterial hypertension and its complications. J Edu Health Sport. 2019;9(5):265-279. http://dx.doi.org/10.5281/zeno....
 
23.
World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: 2009.
 
24.
OECD/EU. Health at a Glance: Europe 2018: State of Health in the EU Cycle, OECD Publishing, Paris,2018. https://doi.org/10.1787/health... (access: 2020.10.09).
 
25.
Eurostat. Member States spent over €1000 billion on health, 2017. https://ec.europa.eu/eurostat/... (access: 2020.10.09).
 
26.
World Health Organization. Noncommunicable diseases: what ministries of education need to know. Geneva: World Health Organization for the UN Interagency Task Force on NCDs, 2016. https://apps.who.int/iris/bits... (access: 2020.10.09).
 
27.
Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum,2011.
 
28.
Leśniowsa J. Obciążenie systemu ochrony zdrowia i gospodarki kosztami generowanymi przez przewlekłe choroby niezakaźne. Kolegium Zarządzania i Finansów. 2018;167:79-93.
 
29.
Cybulska B, Szostak WB, Filipiak KJ, et al. Polish Forum for Prevention Guidelines on Dyslipidaemia. Kardiol Pol. 2017; 75(2): 187–190, DOI: 10.5603/KP.2017.0031.
 
30.
Suligowska K, Gajewska M, StokwiszewskiJ, et al. Niedostateczna wiedza Polaków na temat kryteriów nadciśnienia tętniczego i jego powikłań — wyniki badania NATPOL 2011. Nadciśnienie Tętnicze. 2014; 18( 1): 9-18.
 
31.
Jarząbek K, Kozłowska A, NiedzielaJ, et al. Knowledge of risk factors for coronary artery disease in the population of Lublin and Swietokrzyskie voivodeships in Poland. Folia Cardiolog. 2015; 10(1): 9–16.
 
32.
Piwońska A, Piotrowski W, Piwoński J, et al. Cardiovascular health knowledge of the Polish population. Comparison of two national multi-centre health surveys: WOBASZ and WOBASZ II. Kardiol Pol. 2017; 75(7): 711–719. DOI: 10.5603/KP.a2017.0070, indexed in Pubmed: 28394004.
 
33.
Nowicki G, Ślusarska B, Brzezicka A. Analiza stanu wiedzy o czynnikach ryzyka chorób układu sercowo-naczyniowego wśród osób pracujących. Nursing Topics. 2009; 17(4): 321–327.
 
34.
Zdrojewski T, Wyrzykowski B, Szczęch R, et al. Steering Committees of the Programmes NATPOL PLUS; SMS: the Polish 400 Cities Project. Epidemiology and prevention of arterial hypertension in Poland. Blood Press Suppl. 2005; 2: 10–16.
 
35.
Zdrojewski T, Rutkowski M, Bandosz P, et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol. 2013; 71: 381–392.
 
36.
Balwicki Ł, Zdrojewski T, Bandosz P, et al. Świadomość nadciśnienia tętniczego a pa-lenie papierosów wśród dorosłych Polaków. Arterial Hypertens. 2010; 14(3): 196–200.
 
37.
Perk J, De Backer G, Gohlke H, et al. Europejskie wytyczne dotyczące zapobiegania chorobom serca i naczyń w praktyce klinicznej na rok 2012. Kardiol Pol. 2012; 70: 1–99.
 
38.
Zdrojewski T. Częstość występowania i świadomość nadciśnienia tętniczego w Polsce i na świecie. Post Nauk Med. 2011; 4: 4-10.
 
39.
Tomiak E, Chlabicz S, Mizgała E,et al. Prevention of cardiovascular disease in a rural general practice. Ann Agric Environ Med. 2016; 23(4): 553–558. DOI: 10.5604/12321966.1226845.
 
40.
United States Preventive Services Task Force. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 320: 272-280.
 
41.
Arent-Piotrowska K. Hipercholesterolemia – zmora dzisiejszych czasów. Co zrobić, by zapobiec jej konsekwencjom w świetle aktualnych zaleceń kardiologicznych. Probl Hig Epidemiol. 2018, 99(2): 108-113 .
 
42.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. A Report of the American College of Cardiology/American Heart Association: Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 74: 1376-1414.
 
43.
National Institute for Health and Care Excellence. Familial hypercholesterolaemia: identification and management. https://www.nice.org.uk/guidan... (access: 2021.02.26).
 
44.
Whelton P, Carey R, Wilbert S, et al. 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2017; 71: 127-248.
 
45.
Krzywińska-Wiewiorowska M, Stawińska-Witoszyńska B, Krzyżaniak A, et al.. Environmental variation in the prevalence of hypertension in children and adolescents – is blood pressure higher in children and adolescents living in rural areas? Ann Agric Environ Med. 2017; 24(1): 129–133. DOI: 10.5604/12321966.1230678.
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top